Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Insulin aspart, human price, strengths & recalls

Generic of NovoLog, Fiasp, Merilog

Pharmacies pay $134.41 for 15 mL of Insulin aspart, human 100 units/mL, 3 mL pen this week, and from $69.55 to $134.41 across its 3 priced strengths and forms. 3 manufacturers make it. It has 5 recalls on record, none ongoing. Its official label last changed on June 17, 2026.

Generic
Pharmacies pay$134.41for 15 mL of 100 units/mL, 3 mL penNo change in 4 weeks
Fair cash price
$165.07
Strengths
3
Makers
3
Updated
Nov 11

Insulin aspart, human price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
100 units/mL, 3 mL cartridge$8.57$128.56 / 15 mLNo change-0.3%
100 units/mL injection$6.95$69.55 / 10 mLNo change+0.1%
100 units/mL, 3 mL pen$8.96$134.41 / 15 mLNo change+0.1%

Brand names of insulin aspart, human

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Medicare negotiated price

$495.00$119.00-76%

Medicare negotiated a maximum fair price of $119.00 for a 30-day supply of NovoLog / Fiasp, against a 2023 list price of $495.00. It has applied since January 1, 2026.

What this means for patients

  • The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
  • What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
  • Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
  • If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Every Medicare negotiated price

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls5 recalls on record

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for insulin aspart, human? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 17, 2026
Version6 of 6
EffectiveFeb 28, 2023
Read the label

These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART.INSULIN ASPART injection, for subcutaneous or intravenous useInitial U.S. Approval: 2000This product is NovoLog (insulin aspart).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
BLA020986 · Novo Nordisk Inc
First approved
June 7, 2000 (26 years ago)
Latest approved change
February 28, 2023
Approved label
PDF, Mar 1, 2023
Generic makers
None on the market

Insulin aspart, human questions

How much does insulin aspart, human cost without insurance?

Pharmacies pay about $134.41 for 15 mL of insulin aspart, human 100 units/mL, 3 mL pen ($8.96 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $165.07. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of insulin aspart, human?

Insulin aspart, human is sold as NovoLog, Fiasp, Merilog. The generic has the same active ingredient and usually costs far less.

Is insulin aspart, human in shortage?

No shortage is reported for insulin aspart, human right now. We check the national shortage list every day.

Has insulin aspart, human been recalled?

5 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the insulin aspart, human label last change?

The official label was last updated on June 17, 2026 (version 6). See what changed.

Does Medicare have a negotiated price for Insulin aspart, human?

Yes: $119.00 for a 30-day supply of NovoLog / Fiasp, from January 1, 2026. What you pay still depends on your plan.

Talk about insulin aspart, human

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.